CYTH3 — patent landscape

Top predicted compounds (top 20 by supporting neighbours, then confidence)

Compound	Confidence	Supporting neighbours
SCHEMBL15777646	0.77	2/20
SCHEMBL9235487	0.76	2/20
SCHEMBL28895714	0.71	2/20
SCHEMBL15777853	0.71	2/20
SCHEMBL28433444	0.66	2/20
SCHEMBL15777239	0.65	2/20
SCHEMBL17897744	0.65	2/20
SCHEMBL5212053	0.65	2/20
SCHEMBL17897743	0.64	2/20
SCHEMBL5448364	0.57	2/20
SCHEMBL17897753	0.57	2/20
SCHEMBL2346973	0.57	2/20
SCHEMBL28897000	0.56	2/20
SCHEMBL28437427	0.55	2/20
SCHEMBL17897770	0.54	2/20
SCHEMBL15779069	0.49	2/20
SCHEMBL17891682	0.46	2/20
SCHEMBL15777345	0.45	2/20
SCHEMBL9241040	1.00	1/20
SCHEMBL9289577	1.00	1/20

Clinical trials — most relevant to CYTH3 by text similarity (a relevance ranking, not an exhaustive list)

Trial	Phase	Status
Effects of Cannabidiol (CBD) on the Activation of Autophagy and Inflammation Genes, Functional Consequences in Virologically Controlled HIV-infected Patients	PHASE2	COMPLETED
CISH Inactivated TILs in the Treatment of NSCLC	PHASE1/PHASE2	WITHDRAWN
A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas	PHASE2	COMPLETED
Reverse Transcriptase Inhibitors in AGS	PHASE2	COMPLETED
Nilotinib in Huntington's Disease	PHASE1	UNKNOWN
Assessing the Immunogenicity of pING-hHER3FL	PHASE1	ACTIVE_NOT_RECRUITING
Neutrophils as Prognostic Factors in Granulomatosis With Polyangiitis (Formerly Named Wegener's Granulomatosis)	nan	COMPLETED
Chromosome 5Q Gene Variants and Asthma-Related Traits	nan	COMPLETED
NCF Gene & TNFSF4 in SLE Patients	nan	UNKNOWN
Autophagy Bladder Cancer	nan	UNKNOWN
Genetic Characterization of Parkinson's Disease	nan	COMPLETED
Identification of Genes Predisposing to Atherosclerosis	nan	COMPLETED
Immunological Profile and Clinical Characteristics of Children Diagnosed With Chronic Granulomatous Disease	nan	UNKNOWN
Family Blood Pressure Program - GENOA	nan	COMPLETED
Family Blood Pressure Program - SAPPHIRe Network	nan	COMPLETED
Family Blood Pressure Program - HyperGEN	nan	COMPLETED
Observational Study of Blood Treated With Cytolin	nan	COMPLETED
The Mechanistic Biology of Primary Immunodeficiency Disorders	nan	RECRUITING
Genetic Variants Associated With Adolescent Suicide Attempts	nan	COMPLETED
Pulmonary Hypertension, Hypoxia and Sickle Cell Disease	nan	COMPLETED
The Etiology and Progression of Brain Tumors	nan	COMPLETED
Inflammatory Genomics in Human Carotid Artery Disease	nan	COMPLETED
Study of Usher Syndromes, Type 1 and Type 2	nan	COMPLETED
Gene Analysis of Parkinson's Disease	nan	COMPLETED
Study of the Pathophysiological Mechanisms Involved in Bleeding Events	nan	COMPLETED
Assessing the Polygenic Burden of Rare Disruptive Mutations in Parkinson's Disease	nan	UNKNOWN
Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH)	nan	COMPLETED
Screening of Lysosomal Storage Disorders Diseases in Minority Groups	nan	UNKNOWN
Susceptibility Genes in Autism Spectrum Disorders	nan	COMPLETED
Circulating Markers for Ischemic Heart Disease	nan	RECRUITING

Related proteins — ESM-2 sequence neighbours (a CYTH3 binder may also engage these)

Protein	Name	Similarity
P97696	—	1.000	P97696 →
O08967	—	1.000	O08967 →
P63035	—	1.000	P63035 →
P63034	—	1.000	P63034 →
Q9QX11	—	1.000	Q9QX11 →
Q15438	—	1.000	Q15438 →
P97694	—	0.999	P97694 →
Q80YW0	—	0.995	Q80YW0 →
Q76MZ1	—	0.995	Q76MZ1 →
Q76MY7	—	0.994	Q76MY7 →
CYTH2	Cytohesin-2	0.992	landscape →
Q9UIA0	—	0.990	Q9UIA0 →
Q2KI41	—	0.989	Q2KI41 →
P52735	—	0.981	P52735 →
Q9H8V3	—	0.975	Q9H8V3 →
A0A3Q1LSX9	—	0.974	A0A3Q1LSX9 →
Q3UYK3	—	0.974	Q3UYK3 →
Q4KWH5	—	0.973	Q4KWH5 →
Q07139	—	0.973	Q07139 →
Q9R0C8	—	0.973	Q9R0C8 →
Q6NXC0	—	0.972	Q6NXC0 →
G3X9K3	—	0.972	G3X9K3 →
Q28BK1	—	0.972	Q28BK1 →
Q5SVR0	—	0.971	Q5SVR0 →
Q15111	—	0.971	Q15111 →
O46382	—	0.971	O46382 →
Q9Y6D5	—	0.971	Q9Y6D5 →
Q4KWH8	—	0.971	Q4KWH8 →
Q8K4M9	—	0.970	Q8K4M9 →
Q00944	—	0.970	Q00944 →